Broker Recommendations

Berenberg cuts Hikma price target after update, maintains 'buy'

By Michele Maatouk

Date: Friday 07 Nov 2025

(Sharecast News) - Berenberg cut its price target on Hikma Pharmaceuticals on Friday to 2,300p from 2,510p following the company's trading update a day earlier, in which it downgraded medium-term guidance for the injectables unit.
It noted that Hikma maintained its FY25 segmental guidance, but lowered its medium-term core operating profit...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page